Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Journal:
Current Drug Metabolism
Volume:
5
Page:
463-481
Author(s):
Oliver Langer and Markus Muller
ET-18-OCH3 (Edelfosine): A Selective Antitumour Lipid Targeting Apoptosis Through Intracellular Activation of Fas / CD95 Death Receptor
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
3163-3184
Author(s):
Faustino Mollinedo, Consuelo Gajate, Sonsoles Martin-Santamaria and Federico Gago
Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
4081-4101
Author(s):
Veronic Marie Isabelle Provencher, Ersilia Coccaro, Jonathan Jacques Lacasse and Luis Maria Schang
“Virostatics” as a Potential New Class of HIV Drugs
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
4103-4120
Author(s):
L. M. Kelly, J. Lisziewicz and F. Lori
Current Biological Therapies for Inflammatory Bowel Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
4127-4147
Author(s):
Daniel C. Baumgart and Axel U. Dignass
Herpes Simplex Virus Type 1 Amplicons and their Hybrid Virus Partners, EBV, AAV, and Retrovirus
Journal:
Current Gene Therapy
Volume:
4
Page:
385-408
Author(s):
Angelika Oehmig, Cornel Fraefel, Xandra O. Breakefield and Mathias Ackermann
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
621-635
Author(s):
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
637-651
Author(s):
N. G. Nikitakis, H. Siavash and J. J. Sauk
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
653-671
Author(s):
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
673-687
Author(s):
R. Eaveri, A. Ben-Yehudah and H. Lorberboum-Galski